XWXiu L. Wang

Xiu L. Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiu L. Wang has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Peter Hillemanns

    Department of Obstetrics and Gynecology, Medical School Hanover, Hanover, Germany

    2 shared publications
  • Christian Dannecker

    Laser research institute, Klinikum Grosshadern, Munich University, Munich, Germany

    1 shared publication
  • H.S. Wang

    Department of Dermatology and Venereology, Shanghai Dermatosis and STD Hospital, Wuyi Road, Shanghai 200050, China

    1 shared publication
  • H.W. Wang

    Department of Dermatology and Venereology, Shanghai Dermatosis and STD Hospital, Wuyi Road, Shanghai 200050, China

    1 shared publication
  • Herbert Stepp

    Laser research institute, Klinikum Grosshadern, Munich University, Munich, Germany

    1 shared publication
  • Hong W. Wang

    Department of Dermatology and Venereology, Shanghai Skin Disease and STD Hospital, Shanghai, P. R. China

    1 shared publication

Latest Publications

  • Open Access

    Distinctive Features of Foreskin Condylomata Acuminata Associated with Diabetes Mellitus

    by Xiu L. Wang, Hong W. Wang, Peter Hillemanns, Michael R. Hamblin

    The aim of this study was to test the hypothesis that particular clinical features of foreskin condylomata acuminata in Chinese male patients are associated with diabetes. A prospective study enrolled 126 men presenting with foreskin condylomata acuminata from 2001 to 2006. Mean age was 46 years (age range 25–74 years) and mean duration of disease was 4.8 months (range 1–18 months). Patients were divided into two groups according to clinical features. In group 1, 42 men had distinctive signs such as redundant prepuce, crown warts circling the entire preputial ring, maceration, fissures, phimosis and balanitis, and 37 of 42 (88%) patients were found to have concurrent type 2 diabetes, furthermore 32 of these 37 patients had an insidious onset and were previously undiagnosed. In group 2, 84 male patients did not have those distinctive clinical features and type 2 diabetes was found in only 10 cases (11.9%, p


  • Study of Protoporphyrin IX (PpIX) Pharmacokinetics After Topical Application of 5‐Aminolevulinic Acid in Urethral Condylomata Acuminata†

    by Xiu‐Li Wang, Hong‐Wei Wang, Zheng Huang, Herbert Stepp, Reinhold Baumgartner, Christian Dannecker, Peter Hillemanns

    The pharmacokinetics of 5‐aminolevulinic acid (ALA)‐induced protoporphyrin IX (PpIX) in lesions of urethral condylomata acuminata were investigated. Sixty patients (20 to 60 years old, 48 male and 12 female) were divided randomly into five groups and received topic application of different concentrations of ALA solution (0.5%, 1%, 3%, 5% or 10%). Biopsy was performed between 1 and 7 h and specimens were subjected to histological, PpIX fluorescence and human papillomavirus (HPV) DNA typing analyses. Fluorescence examination confirmed that ALA‐induced PpIX fluorescence was dominantly distributed in the HPV‐infected epidermis. In contrast, only a minimal amount of PpIX fluorescence was detected in the dermis. The maximal fluorescence intensity was detected at 5 h incubation. Higher ALA concentration (e.g. 5% and 10%) produced a stronger intensity. These results suggest that the topical application of 5–10% ALA solution for 3–5 h is the optimal condition for the photodynamic therapy of urethral condylomata acuminata. The selective damage of the condylomata acuminata lesions in the epidermis without damaging the dermis ensures a better control of recurrence and side effects such as ulceration or scarring. DNA typing showed that all patients were positive for low risk‐HPV DNA and among them 18.3% of patients harbored high risk‐HPV DNA.


  • Topical 5-aminolaevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata

    by X.L. Wang, H.W. Wang, H.S. Wang, S.Z. Xu, K.H. Liao, P. Hillemanns

    Background Electrocoagulation and laser evaporation for urethral condylomata acuminata have high recurrence rates and can be associated with urethral malformations. Objectives To investigate the effect of photodynamic therapy (PDT) with topical 5‐aminolaevulinic acid (ALA) on urethral condylomata acuminata and to examine the histological changes in lesions of condylomata acuminata after ALA‐PDT. Methods Patients with urethral condylomata (n = 164) were given topical ALA followed by intraurethral PDT through a cylindrical fibre. Patients included 11 individuals with 16 penile or vulval condylomatous lesions which were biopsied before or after treatment; the histological changes were then evaluated by light microscopy and electron microscopy. Results The complete response rate was 95% and the recurrence rate was 5% after 6–24 months of follow‐up. Light microscopy revealed keratinocytes in the middle and upper layers of the epidermis showing marked vacuolation and some necrocytosis 1 and 3 h after PDT. Necrosis in all layers of the epidermis was noted 5 h after PDT. Electron microscopy of keratinocytes revealed distinct ultrastructural abnormalities of mitochondria and the endoplasmic reticulum, and membrane damage. Apoptotic bodies were detected 3 h after PDT and a large number of keratinocytes exhibited necrosis 5 h after PDT. Conclusions Results suggest that, compared with conventional therapies, topical ALA‐PDT is a simple, effective, safe and well‐tolerated treatment for urethral condylomata acuminata that is associated with a low recurrence rate. The mechanism might be the triggering of both apoptosis and necrosis by ALA‐PDT in human papillomavirus‐infected keratinocytes.